itraconazole and Prostatic Neoplasms, Castration-Resistant

itraconazole has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ajiboye, AS; Antonarakis, ES; Blackford, AL; Carducci, MA; Danila, DC; Frost, A; Heath, EI; Kachhap, SK; King, S; Mendonca, J; Rathkopf, D; Rudek, MA; Smith, DC; Zhao, M	1

Trials

1 trial(s) available for itraconazole and Prostatic Neoplasms, Castration-Resistant

Article	Year
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. The oncologist, 2013, Volume: 18, Issue:2 Topics: Antineoplastic Agents; Disease Progression; Dose-Response Relationship, Drug; Humans; Itraconazole; Male; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome; Vascular Endothelial Growth Factor A	2013

Article

Year

Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

The oncologist, 2013, Volume: 18, Issue:2

Topics: Antineoplastic Agents; Disease Progression; Dose-Response Relationship, Drug; Humans; Itraconazole; Male; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome; Vascular Endothelial Growth Factor A

2013